House panel holds hearing on medical device tax repeal

03/6/2013 | MassDevice.com (Boston) · Hill, The

The 2.3% medical device tax could cost jobs and stymie the development of new products, Rep. Charles Boustany, R-La., said in testimony before the House Ways and Means Committee. In later comments to reporters, he said that efforts to repeal the levy may be considered "in the context of fundamental tax reform," echoing comments previously made by the medtech industry.

View Full Article in:

MassDevice.com (Boston) · Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA